Piroxicam and 5'-hydroxypiroxicam kinetics following multiple dose administration of piroxicam.
C J Richardson, K L Blocka, S G Ross, R K Verbeeck
Index: Eur. J. Clin. Pharmacol. 32(1) , 89-91, (1987)
Full Text: HTML
Abstract
Piroxicam (20 mg once daily) was administered orally to six healthy young volunteers for 15 days. Trough steady-state levels of piroxicam and 5'-hydroxypiroxicam were 5.5 and 1.2 micrograms/ml, respectively. Piroxicam's plasma half-life (54.9 h) was significantly shorter than that of 5'-hydroxypiroxicam (70.5 h). Percent unbound piroxicam and 5'-hydroxypiroxicam in plasma at steady-state averaged 1.10 and 8.07 respectively. An average of 25.2% of the dose was recovered in urine as 5'-hydroxypiroxicam; approximately two-thirds (17.2%) in the form of the glucuronide conjugate. Average steady-state plasma levels (Css) of piroxicam (7.0 micrograms/ml) were significantly higher than predicted from a previously reported single dose study (5.3 micrograms/ml).
Related Compounds
Related Articles:
[The binding of oxicam derivatives to human serum albumin].
1988-08-01
[Arzneimittelforschung 38(8) , 1089-92, (1988)]
[J. Chromatogr. A. 382 , 382-8, (1986)]
[J. Chromatogr. A. 576(1) , 121-8, (1992)]
1995-11-03
[J. Chromatogr. B, Biomed. Appl. 673(1) , 142-6, (1995)]
1998-08-01
[Analyst 123(8) , 1749-52, (1998)]